#biotech

Last 24h 📊 Neutral 📈3 📉1 📊4

Last 7 Days 📊 Neutral 📈11 📉4 📊21

Last 30 Days 📊 Neutral 📈79 📉9 📊81

Release 📈 Stocks

Arthex Biotech Appoints Glenn P. Sblendorio as New Chairman

September 29, 2026 (42 days ago)

Arthex Biotech strengthens its leadership team with the appointment of Glenn P. Sblendorio as Chairman to guide the company's strategic expansion and…

ARTHEx Biotech

🌍 EUROPE Read More →

Release 📈 Stocks

Viking Therapeutics Raises $575 Million via Upsized Equity and Debt Offering

September 28, 2026 (42 days ago)

Viking Therapeutics secures $575 million through a dual-offering of stock and convertible notes, strengthening its cash position for ongoing clinical development despite…

VKTX

🌍 AMERICAS Read More →

Release 📈 Stocks

Fondazione Telethon Launches WASKYRA as First US-Approved Wiskott-Aldrich Therapy

September 28, 2026 (43 days ago)

Fondazione Telethon brings WASKYRA to the US market, establishing a new standard of care for Wiskott-Aldrich Syndrome patients as the organization scales…

Fondazione Telethon

🌍 AMERICAS Read More →

Release 📈 Stocks

Lakewood-Amedex Reports Positive Nu-3 Data for Diabetic Foot Ulcer Treatment

September 28, 2026 (43 days ago)

Lakewood-Amedex shares gain momentum as the company reports successful clinical data for its Nu-3 Bisphosphocin candidate, targeting the treatment of diabetic foot…

LABT

🌍 AMERICAS Read More →

Release 📈 Stocks

Biohaven Shares Eye Gains as BHV-1530 Data Selected for ENA 2026 Presentation

September 28, 2026 (43 days ago)

Biohaven's BHV-1530 Phase 1 study data will be presented at the ENA 2026 symposium, marking a significant clinical milestone for the company's…

BHVN

🌍 AMERICAS Read More →

Release 📈 Stocks

Xilio Therapeutics Appoints Dr. Houvras as New Chief Medical Officer

September 28, 2026 (43 days ago)

Xilio Therapeutics strengthens its leadership team with the appointment of Dr. Houvras, a veteran in translational medicine and immuno-oncology, to oversee clinical…

XLO

🌍 AMERICAS Read More →

Release 📈 Stocks

Kodiak Sciences Zenkuda Hits Primary Endpoint in Wet AMD Study

September 28, 2026 (43 days ago)

Kodiak Sciences shares rally as Zenkuda demonstrates clinical efficacy in wet AMD, establishing a potential new standard of care with durable 24-week…

KOD

🌍 AMERICAS Read More →

News 📈 Stocks

Disc Medicine Shares Face Pressure as Rosen Law Firm Launches Investigation

September 27, 2026 (44 days ago)

Rosen Law Firm is investigating Disc Medicine, Inc. over potential securities violations, putting downward pressure on IRON shares as investors assess the…

IRON

🌍 AMERICAS Read More →

Release 📈 Stocks

STEMREGEN Posts 1,017% Growth to Secure Third Consecutive Inc. 5000 Ranking

September 26, 2026 (45 days ago)

STEMREGEN secures its third consecutive Inc. 5000 appearance, reporting a 1,017% three-year growth rate and a national ranking of No. 332 as…

STEMREGEN

🌍 AMERICAS Read More →

News 📈 Stocks

Incyte Shares Rally 22% as Company Raises FY2026 Sales Guidance

September 24, 2026 (47 days ago)

Incyte stock maintains strong momentum, trading above key moving averages after reporting robust Q2 growth and lifting its long-term revenue outlook.

INCY EXEL XBI

🌍 AMERICAS Read More →

News 📈 Stocks

Abeona Therapeutics Reports 31% Revenue Growth as ZEVASKYN Launch Accelerates

September 24, 2026 (47 days ago)

Abeona Therapeutics sees strong commercial momentum for its RDEB therapy ZEVASKYN, reporting 31% revenue growth and broad market access despite ongoing administrative…

ABEO

🌍 US Read More →

News 📈 Stocks

ImmunityBio Shares Rally 9.94% Following Founder Meeting with Erdogan

September 24, 2026 (47 days ago)

ImmunityBio shares surged nearly 10% on Tuesday as a high-profile meeting between founder Dr. Patrick Soon-Shiong and Turkish President Erdogan signaled potential…

IBRX

🌍 GLOBAL Read More →